Press Releases

HHS Extends Deadline for Bidders in Competitive Range for Recombinant Anthrax Vaccine (rPA) Contract to Submit Development Plan to FDA for Review to June 15, 2009

...

New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South Africa

...

Emergent BioSolutions to Release First Quarter 2009 Financial Results and Conduct a Conference Call on May 7, 2009

...

HHS Requires Bidders in Competitive Range for Recombinant Anthrax Vaccine (rPA) Contract to Submit Development Plan to FDA for Review

...

Emergent BioSolutions Announces Commencement of Phase I/II Clinical Trial of Anthrax Immune Globulin for Treating Anthrax Disease

...

Emergent BioSolutions Reports Financial Results for Full Year 2008

...

Emergent BioSolutions to Webcast Presentation at the Cowen & Co. 29th Annual Health Care Conference on Tuesday, March 17, 2009

...

Emergent BioSolutions Announces That BioThrax (Anthrax Vaccine Adsorbed) Receives Market Authorization in India

...

Emergent BioSolutions to Release Full Year 2008 Financial Results and Conduct a Conference Call on March 5, 2009

...

Emergent BioSolutions Provides Preliminary 2008 Financial Results and Guidance for 2009

...

Emergent BioSolutions Recognized by Security Magazine Among Best Security Organizations

...

Emergent BioSolutions Ends Efforts to Acquire Protein Sciences

...